Biological therapy in psoriasis treatment

Marta Woźniak; Roman Nowicki

Abstract

10/2005 vol. 8

Biological therapy in psoriasis treatment

Marta Woźniak

,

Roman Nowicki

Przew Lek 2005; 10; 65-68

Online publish date: 2005/12/22

View full text

AMA

Woźniak M, Nowicki R. Biological therapy in psoriasis treatment. Przewodnik Lekarza/Guide for GPs. 2005:65-68.

APA

Woźniak, M., & Nowicki, R. (2005). Biological therapy in psoriasis treatment. Przewodnik Lekarza/Guide for GPs, 65-68.

Chicago

Woźniak, Marta, and Roman Nowicki. 2005. "Biological therapy in psoriasis treatment". Przewodnik Lekarza/Guide for GPs: 65-68.

Harvard

Woźniak, M., and Nowicki, R. (2005). Biological therapy in psoriasis treatment. Przewodnik Lekarza/Guide for GPs, pp.65-68.

MLA

Woźniak, Marta et al. "Biological therapy in psoriasis treatment." Przewodnik Lekarza/Guide for GPs, 2005, pp. 65-68.

Vancouver

Woźniak M, Nowicki R. Biological therapy in psoriasis treatment. Przewodnik Lekarza/Guide for GPs. 2005:65-68.

Psoriasis is a chronic, immune-mediated disorder that usually requires long-term treatment for control. Despite the availability of numerous therapeutic options, the long-term systemic management of psoriasis can be complicated by numerous adverse reactions. Biological therapies are designed to modulate key steps in the pathogenesis of psoriasis. Biologicals have demonstrated significant benefit with favou-
rable safety and tolerability profiles.

Keywords

biologicals, efalizumab, alefacept, etanercept, infliximab

Integrated with